SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-068882
Filing Date
2021-05-18
Accepted
2021-05-18 16:41:07
Documents
15
Period of Report
2021-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2116844d1_8k.htm   iXBRL 8-K 27069
2 EXHIBIT 10.1 tm2116844d1_ex10-1.htm EX-10.1 51677
3 EXHIBIT 99.1 tm2116844d1_ex99-1.htm EX-99.1 11042
7 GRAPHIC tm2116844d1_ex99-1img01.jpg GRAPHIC 7254
  Complete submission text file 0001104659-21-068882.txt   292182

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA idra-20210518.xsd EX-101.SCH 3196
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20210518_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20210518_pre.xml EX-101.PRE 22717
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2116844d1_8k_htm.xml XML 3611
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 21936650
SIC: 2836 Biological Products, (No Diagnostic Substances)